The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of ...
https://www.google.com/url?rct=j&sa=t&url=https://reporter.am/2022/08/28/brokerages-set-ocugen-inc-nasdaqocgn-target-price-at-7-00.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw1HwO0qYFL3cIvRXGVfgSd9
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.